WHO ICTRP trial
Optimal intensity of anticoagulation with warfarin in Korean patients with…
KCT0007994 · Clinical Research Information Service (CRIS) · Not Recruiting
Key facts
| Trial ID | KCT0007994 |
|---|---|
| Public title | Optimal intensity of anticoagulation with warfarin in Korean patients with atrial fibrillation: multi-center, randomized controlled trial |
| Scientific title | Optimal intensity of anticoagulation with warfarin in Korean patients with atrial fibrillation: multi-center, randomized controlled trial |
| Primary sponsor | Chonnam National University Hospital |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Not Recruiting |
| Study type | Interventional Study |
| Phase | Phase4 |
| Countries | Korea, Republic of |
| Conditions | Diseases of the circulatory system |
| Interventions | Drug : In this randomized, open-label trial, low intensity anticoagulation (INR 1.6 to 2.6) with warfarin was compared with standard intensity anticoagulation (INR 2.0 to 3.0) for the prevention of thromboembolism and risk of bleeding… |
| Registration date | Dec 12, 2022 |
| Target size | 1022 |
| Registry page | cris.nih.go.kr |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: